Science topic

Metabolic Diseases - Science topic

Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
Questions related to Metabolic Diseases
  • asked a question related to Metabolic Diseases
Question
3 answers
is there any link(s) between insulin resistance and ghrelin resistance?
Relevant answer
Answer
There are well-established links between diet and the development of chronic metabolic diseases such as insulin resistance, type 2 diabetes, obesity, and cardiovascular disease. Diets high in refined carbohydrates, sugars, saturated fats, and processed foods are associated with an increased risk of metabolic disorders, while diets rich in whole grains, vegetables, fruits, and lean proteins are protective.
Links Between Diet and Chronic Metabolic Diseases:
  1. Insulin Resistance: Diets high in refined sugars and saturated fats contribute to hyperglycemia, leading to chronic insulin level elevations. Over time, cells become less responsive to insulin, leading to insulin resistance. Insulin resistance is a major driver of type 2 diabetes and is linked to metabolic syndrome and obesity (Ludwig & Ebbeling, 2018).
  2. Obesity and Cardiovascular Disease: A poor diet can promote excess calorie intake, leading to weight gain and fat accumulation, particularly in the visceral fat around the abdomen, a risk factor for insulin resistance, type 2 diabetes, and cardiovascular diseases (Hu, 2011).
Link Between Insulin Resistance and Ghrelin Resistance:
Ghrelin, known as the "hunger hormone," stimulates appetite and is involved in energy homeostasis. Recent research suggests a link between insulin resistance and ghrelin resistance, especially in the context of obesity:
  1. Ghrelin Resistance in Obesity: In individuals with obesity, ghrelin’s normal signaling is often impaired, leading to ghrelin resistance. This contributes to dysregulated appetite control and excessive food intake. The exact mechanism is not fully understood, but hyperinsulinemia (a consequence of insulin resistance) is believed to play a role in blunting ghrelin's effects on the brain, particularly in areas that regulate hunger and satiety (Ueno et al., 2018).
  2. Insulin Resistance and Ghrelin: Insulin and ghrelin are interlinked through their roles in regulating energy balance. Insulin resistance can influence ghrelin secretion and function. In conditions like metabolic syndrome and type 2 diabetes, insulin resistance is often associated with altered ghrelin dynamics, further complicating appetite regulation and glucose metabolism (Delhanty et al., 2012).
References:
  • Ludwig, D. S., & Ebbeling, C. B. (2018). The carbohydrate-insulin model of obesity: Beyond “calories in, calories out”. JAMA Internal Medicine, 178(8), 1098-1103.
  • Hu, F. B. (2011). Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care, 34(6), 1249-1257.
  • Ueno, H., et al. (2018). Ghrelin resistance in obesity: Effect on feeding behavior and energy balance. Current Diabetes Reports, 18(10), 123.
  • Delhanty, P. J., et al. (2012). The role of ghrelin in glucose homeostasis. Current Diabetes Reviews, 8(5), 314-328.
  • asked a question related to Metabolic Diseases
Question
7 answers
To GDC2030@who.int Respected, Sir/ Madam I want to draw your attention towards the diabetes eradication program. Diabetes is a metabolic disorder and it is not correct by any Medicine, Substitute, Yoga or Exercise. If possible please tell me. In our body first diabetes1 comes and after some time it changes into diabetes 2 I request you and your team, Please read my book Your Health Is In Your Mouth English https://www.lulu.com/account/projects/zgvvk6 Hindi https://www.flipkart.com/aapka-swasth-aapke-muh-me/p/itm22edae101e74a?pid=9789393385543 I want your company Looking forward to hearing from you soon.
Relevant answer
Answer
We can be happy when we are healthy if we are not healthy then we cannot enjoy life. We always think about our body problems. Nowadays days Diabetes and other metabolic problems are epidemic in the world. And no medicine or substitute to cure them. The main causes of metabolic disorders are remineralisations of saliva, lipids hormones and biosynthesis in our body. To solve the problems Please read the book “Your Health Is In Your Mouth” Links: - https://www.amazon.in/Health-Mouth-Innovator-Pramod-Stephen/dp/1387414453English
  • asked a question related to Metabolic Diseases
Question
4 answers
1. Please explain Biochemical levels in biochemistry.
2.Relationship between genetic mutations and metabolic disorders.
Relevant answer
Answer
1. Biochemical levels in biochemistry.
If you notice at the cellular level, homeostasis is observable in the biochemical reactions that take place. Regulation of pH, temperature, oxygen, ion concentrations, and blood glucose concentration is necessary for enzymes to function optimally in the environment of the cell, and the formation of waste products must be kept in control as not to disrupt the internal environment of the cells as well. The cell will remain alive as long as the internal environment is favorable and can be a functioning part of the tissue to which it belongs.
So, maintaining homeostasis (self-regulating process by which stability is maintained while adjusting to conditions that are best for survival) is important as it ensures that the body's internal milieu remains steady and continuous, enabling it to function at its best, and is crucial to its daily activities.
2. Relationship between genetic mutations and metabolic disorders.
Metabolism is a complex set of chemical reactions that your body uses to maintain life. These include making energy such as special enzymes that break down food or certain chemicals so your body can use them right away for fuel or store them for later use, and getting rid of substances that your body no longer needs. When these processes don't work properly, a metabolic disorder occurs. It may be due to an enzyme that's too low or missing or due to another problem.
Most metabolic disorders are caused by the genetic deficiency of an enzyme that is needed to convert one chemical into another. Whenever a random mutation happens in the coding DNA that codes for the enzyme, wrong amino acids could be used to make the enzyme. This could change the shape of the enzyme's active site resulting in an enzyme that does not function normally.
You may have heard about Inherited Metabolic Disorders which are medical conditions caused by changes in specific genes that affect metabolism. Different gene changes cause different types of Inherited Metabolic Disorders. These gene changes are mostly passed down from both parents. But sometimes the gene change comes only from one parent, most often from the mother. These disorders are also called Inborn Errors of Metabolism.
For instance, Gaucher's disease which you have mentioned, is an inborn error of metabolism due to the accumulation of glucocerebroside lipids. Toxic accumulation inborn errors of metabolism fall into 3 major categories: localized toxicity, circulating toxicity, or a combination of both. Gaucher's disease is an example of localized toxicity.
Another example is Phenylketonuria (PKU) which is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is caused by mutations in the gene that helps make an enzyme called phenylalanine hydroxylase (PAH). This enzyme is needed to convert the amino acid phenylalanine into other substances like tyrosine which the body needs. When this gene, known as the PAH gene, is defective, the body cannot break down phenylalanine. As a result, phenylalanine accumulates and is toxic to the brain. Without treatment, most people with PKU would develop severe intellectual disability.
Hope this explanation is helpful!
Best.
  • asked a question related to Metabolic Diseases
Question
3 answers
Metabolic disorders occur due to our proper habits of eating process and remineralisation in the mouth. Like food, water, and liquids, etc. Due to mutations in all our food in saliva, the imbalance of minerals in our body parts and some parts of our body and endocardial gland malfunction. If we do not change our habits, then we will feel difficulties, and these habits, abnormalities, and things are going to our inborn children. And problems are increasing day by day. We are seeing that our inborn children suffer from metabolic disorders from birth, like diabetes, etc. These habits, abnormalities, and genes we cannot correct with any medicine, substitutes, or research like stem cells, gene therapy, etc. "Habits Is a Second Nature “I request all people. Please read my book and follow the eating rules. Then we can achieve victory over metabolic disorders. I welcome all of you at these links:- https://www.lulu.com/shop/innovator-pramod-stephen/your-health-is-in-your-mouth/paperback/product-zgvvk6.html?page=1&pageSize=4 https://www.flipkart.com/aapka-swasth-aapke-muh-me/p/itm22edae101e74a?pid=9789393385543
Relevant answer
Answer
Good answer, But, Can you say that or give proof like diabetes or any other metabolic abnormities cured by medications, dietary changes, and lifestyle modifications?
  • asked a question related to Metabolic Diseases
Question
2 answers
Universal question: - Can diabetes & metabolic disorders be cured by any medicine and substitute? For answer: - https://www.lulu.com/shop/innovator-pramod-stephen/your-health-is-in-your-mouth/paperback/product-zgvvk6.html?page=1&pageSize=4 सार्वभौमिक प्रश्न:- क्या मधुमेह और चयापचय संबंधी विकारों को किसी दवा और विकल्प से ठीक किया जा सकता है? उत्तर के लिए:-https://www.flipkart.com/aapka-swasth-aapke-muh-me/p/itm22edae101e74a?pid=9789393385543
Relevant answer
Answer
Yes, gout is considered a metabolic disease. It is a type of arthritis that results from the buildup of uric acid in the body, typically due to the body's inability to process or excrete it properly. This condition is often associated with metabolic factors such as diet, obesity, and genetics.
The metabolic cause of gout is primarily due to deficiency or alteration in the enzyme called xanthine oxidase. Xanthine oxidase is responsible for catalyzing the conversion of hypoxanthine and xanthine to uric acid as part of the purine degradation pathway. This enzyme plays a critical role in the final step of purine metabolism, leading to the production of uric acid. An excess of uric acid in the body, often due to factors such as diet, genetics, or kidney function, can contribute to conditions like gout, where uric acid crystals can accumulate in joints, leading to pain and inflammation. Drugs like allopurinol like allopurinol can be used to treat gout. Allopurinol is a medication commonly used in the treatment of conditions like gout and hyperuricemia (high levels of uric acid in the blood). It works by inhibiting the enzyme xanthine oxidase, which is involved in the production of uric acid. By reducing the activity of xanthine oxidase, allopurinol helps lower uric acid levels in the body. This, in turn, can prevent gout attacks and reduce the risk of uric acid crystal formation in joints and other tissues. Allopurinol is typically taken orally as a prescription medication and is considered a long-term treatment for managing conditions related to excessive uric acid production.
  • asked a question related to Metabolic Diseases
Question
8 answers
Diabetes is most prevalent all over the world especially type-II diabetes.  India is called the  'Diabetic Capital'  as this metabolic disorder is most prevalent in our country  Therefore, is there anything like signature medicine  or advanced  genetic engineering tool for type-II diabetes to have sigh of relief for the  patients ?
Relevant answer
Answer
The first type of diabetes that occurs in our body is Diabetes type 1 and after a long time of treatment our body becomes resistant to the medicine and it converts into diabetes type 2 it gens goes to our fetus and develops from generation to generation. For Metabolic disorders read my book:-"Your Health Is In Your Mouth"
  • asked a question related to Metabolic Diseases
Question
13 answers
Genetic diseases commonly observed in Pakistan include:
Thalassemia, Cystic Fibrosis, Congenital Heart Diseases, Neurological Disorders, Metabolic Disorders.
In your country, which genetic disease you observe most?
Relevant answer
Answer
In India, several genetic diseases are frequently observed, reflecting the country's diverse population and genetic landscape. Among the most prevalent are thalassemia and sickle cell anemia, particularly in regions like Punjab, Gujarat, and eastern India. Cystic fibrosis is also found, albeit less commonly, affecting the lungs and digestive system. Congenital heart diseases, including atrial septal defect and ventricular septal defect, have a higher prevalence, necessitating specialized medical care. Additionally, G6PD deficiency is notable, especially in malaria-endemic areas. These genetic disorders underscore the importance of genetic counseling, early diagnosis, and management to improve the quality of life for affected individuals and reduce their transmission to future generations.
  • asked a question related to Metabolic Diseases
  • asked a question related to Metabolic Diseases
Question
2 answers
Opinions on "Brain Energy, A Revolutionary Breakthrough in Understanding Mental Health and Improving Treatment for Anxiety, Depression, OCD, PTSD, and More" by Christopher M. Palmer, MD.
Relevant answer
Answer
"Wherever your body hurts your soul is there" used to say our older generations. Which seems to be quite correct since animals have interconnecting blood vessels and neurons covering almost all body.
  • asked a question related to Metabolic Diseases
Question
4 answers
Is there any publication that contains this data?
Relevant answer
Answer
Hello!
Ascites in broiler chickens results from an imbalance between the amount of oxygen available and the amount needed to maintain rapid growth rates and high feeding efficiency. Ascites is influenced and/or caused by variables such growth rate, altitude (hypoxia), and ambient temperature because of the link to oxygen requirement.
Toxins from plants like Crotalaria or aflatoxin may harm the liver in chicken. Obstructive cholangiohepatitis, which is brought on by an infection with Clostridium perfringens, is the most typical cause of liver damage and ascites in broiler chickens. Ascites can result from hepatic amyloidosis in breeders as well as meat-type ducks.
For a more detailed explanation, please refer to this article:
Hargis, B. M. (2022, August 4). Ascites syndrome in poultry - poultry. MSD Veterinary Manual. from https://www.msdvetmanual.com/poultry/miscellaneous-conditions-of-poultry/ascites-syndrome-in-poultry
  • asked a question related to Metabolic Diseases
Question
4 answers
Trying to make the most of my time staying at home in this pandemic. I will love you help with articles that give good overview on metabolism and metabolic diseases
Relevant answer
  • asked a question related to Metabolic Diseases
Question
3 answers
Dear Bariatric Surgeons,
The importance of obesity management in patients with BMIs over 50 has not been completely addressed and it should be considered separately from patients with morbid obesity.
Despite standardized guidelines for reporting the outcomes of bariatric/metabolic surgery for patients with severe obesity, new insight into for specific situations such as in patients with BMIs over 50 is needed. In recent decades, there has been an increase in the number of patients with BMI>50 kg/m2 who present unique challenges for bariatric surgeons. Therefore, there is an unmet need to better define their weight loss outcomes. In addition, there is also a need to consider standardizing the surgical management of patients with BMIs over 50.
This survey, if filled out by a large number of bariatric surgeons, would provide important insight into the bariatric surgical procedures performed on patients with BMI>50 and also give insight into their perioperative care.
To the best of our knowledge this would be the first study on this important topic.
In this light we created this survey entitled "The First Survey Addressing Patients with BMIs over 50." We urge all IFSO members to please complete the survey. The information extracted from this survey may positively impact our care for patients with BMIs over 50.
The survey has 50 questions divided in 4 parts which is submitted via Survey Monkey at the link https://www.surveymonkey.com/r/7W9K9FK
The survey has been designed by 15 bariatric surgeons from around the world: Luciano Antozzi, Miguel Carbajo, Sonja Chiappetta, Amirhossein Davarpanah Jazi, Radwan Kassir, Mohammad Kermansaravi, Panagiotis Lainas, Kamal Mahawar, Mario Musella, Chetan Parmar, Shahab Shahabi, Scott Shikora, Ramon Villalonga, Antonio Vitiello, Lorea Zubiaga.
We thank you in advance for your positive action!
Mohammad Kermansaravi
Mario Musella
Scott Shikora
Relevant answer
Answer
nice survey , good job
i think most of the surgeon well try sleeve gastrostomy as first choice , because of the easy of the surgery and the comparable result to bypass.
  • asked a question related to Metabolic Diseases
Question
6 answers
Tay-Sachs disease is a metabolic disorder that is common in Ashkenazi Jewish. Infants with the disease might express deafness, blindness, and/or paralysis. These symptoms are due to loss of neurons as lipid is not metabolized properly which leads to its accumulation on the nerve cells, then subsequently their destructions. A nonsense mutation in HEXAgene lead to form a truncated hexosaminidase A enzyme that is not efficient for lipid metabolism.
1) What is the molecular technology to analyze the product of HEXA gene mutation? (2 marks)
2) Write the principle of this technique?
3) Explain the expected results of this technique if you compared a sample for a Tay-Sachs patient and a sample for a normal control.
  • asked a question related to Metabolic Diseases
Question
3 answers
Chronopharmacology is branch of biological science which deals with daily life, sleep and wake, day and night, feeding and fasting and other effects. we can manage many diseases including diabetes, obesity, and CVDs with help of circadian rhythms or clocks,
you can watch my recent video on chronopharmacology for all the information
Relevant answer
Answer
Circadian rhythm has a bidirectional interaction with almost all metabolic processes. Therefore, understanding the main reason affecting the circadian clock and creating treatment guidelines using circadian rhythm may increase the success of disease treatment. Chronopharmacology, chrononutrition, and chronoexercise are the novel treatment approaches in metabolic balance.
  • asked a question related to Metabolic Diseases
Question
1 answer
They used data from a medical study, which included 1491 volunteers: 737 women and 754 men. All the inquiries were taken in accordance with the Declaration of Helsinki, at the Department of Endocrinology, Diabetes and Metabolic Disorders of the Clinical Centre of Vojvodina in Novi Sad (Serbia) during the morning hours (after overnight fasting).
Relevant answer
Answer
I fallowing
  • asked a question related to Metabolic Diseases
Question
3 answers
I was reading about metabolic disorders caused by the lack of production of a protein. Can a possible treatment be to supplement the patient with that lacking protein, or would the body degrade it before it acts upon it?
Relevant answer
Answer
One example in the positive: Fingernail splintering is not uncommon and is effectively treated by adding gelatin powder to your morning orange juice. I think this may be more important than one realizes since gelatin is the precursor of collagen and collagen is 30% of all the formed protein in the body. Splintering finger nails may be the tip of the iceberg.
  • asked a question related to Metabolic Diseases
Question
7 answers
Treating children known to have metabolic disorders often includes ensuring adequate amount of calories for age and weight to avoid catabolism, that is usually by giving glucose solution 10%.
What is the long term impact of the sugary fluids on these patients?
Does it contribute to generating some degree of insulin resistance?
Can we predict the insulin resistance if so?
will HOMA-IR serve as a good predictor test?
Relevant answer
Answer
Perhaps the “ESPGHAN/ESPEN/ESPR guidelines on pediatric parenteral nutrition: Carbohydrates” and related publications provide the appropriate and practical instructions for glucose infusion in children [1]. Excessive chronic glucose infusion may lead to hyperglycemia, which leads to increased lipogenesis and adipocyte fat deposition along with subsequent hepatic steatosis, elevated hepatic VLDL triglycerides, hypercholesterolemia, and may ultimately cause insulin resistance (IR) [1]. The magnitude of this effect depends individually and is affected by pre-existing metabolic stress or disease [1]. The gold standard for determining IR is the euglycemic–hyperinsulinemic clamp technique [3]. This method is considered invasive, costly, and impractical for large samples. Despite its modest specificity and sensitivity, HOMA-IR is used as an IR surrogate and alternative index in a large number of studies, including those dealing with children [4]. Other IR indexes with varied specificity and sensitivity, as well as purposes, are available [3,4].
References:
[1] Mesotten D, Joosten K, Kempen A, et al. ESPGHAN/ESPEN/ESPR guidelines on pediatric parenteral nutrition: carbohydrates. Clinical Nutrition, 2018; xxx: 1-7. http://dx.doi.org/10.1016/ j.clnu.2018.06.947.
[2] Sanchez-Garc´ıa A, Rodr´ıguez-Gutierrez R, Mancillas-Adame L. et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. International Journal of Endocrinology, 2020; ID 4678526, 7 pages. https://doi.org/10.1155/2020/ 4678526.
[3] van der Aa Marloes P, Catherijne AJK, Anthonius dB, et al. Definition of insulin resistance affects prevalence rate in pediatric patients: a systematic review and call for consensus. Journal of Pediatric Endocrinology and Metabolism, 2017; 30(2):123-131.doi:10.1515/jpem-2016-0242.
  • asked a question related to Metabolic Diseases
Question
191 answers
In most of the communities especially are owned by lower socioeconomic status.Diet contains more of carbohydrate than protein and fat. More carbohydrate after catabolism produce more saturated fatty acids. This may disturb the level of LDL( high ) lead to atherosclerosis.
Relevant answer
Answer
Yes,I agree with you
  • asked a question related to Metabolic Diseases
Question
3 answers
microRNAs have been shown to have a role in prevention of cancer, however are there any articles on its roles in metabolic disease?
Relevant answer
Answer
Feng J, Xing W, Xie L. Regulatory Roles of MicroRNAs in Diabetes. Int J Mol Sci. 2016 Oct 17;17(10). pii: E1729. Review. PubMed PMID: 27763497; PubMed Central PMCID: PMC5085760.
  • asked a question related to Metabolic Diseases
Question
4 answers
Gut microbiota play significant roles in human health. With the help of Next-gen sequencing, we know much about the compositions of bacteria in the gut but little is known about their activities. What is the default state of bacteria in the gut? Are most bacteria living in the gut at near stationary phase with basal metabolic activity? Do they become more active after a meal? Or they are always active? For example, what will a probiotic species do in the gut after they are taken by people? How many and how long will they colonize and grow in the gut?
Relevant answer
Answer
Yes, we need approaches to study their activity in vivo.
  • asked a question related to Metabolic Diseases
Question
2 answers
NAFLD is currently the main cause of chronic liver disease in developed countries, and the number of NAFLD patients is growing worldwide. NAFLD often has similar symptoms to other metabolic disorders, including type 2 diabetes and obesity. Recently, the role of the gut microbiota in the pathophysiology of many diseases has been revealed. Regarding NAFLD, experiments using gut microbiota transplants to germ-free animal models showed that fatty liver disease development is determined by gut bacteria. Moreover, the perturbation of the composition of the gut microbiota has been observed in patients suffering from NAFLD. Numerous mechanisms relating the gut microbiome to NAFLD have been proposed, including the dysbiosis-induced dysregulation of gut endothelial barrier function that allows for the translocation of bacterial components and leads to hepatic inflammation.
I read this article :
Safari, Z. & Gérard, P. Cell. Mol. Life Sci. (2019) 76: 1541. https://doi.org/10.1007/s00018-019-03011-w
Sincerely Angel Carlos Bassols Ricardez, MD
Relevant answer
Answer
Please see the following PDF attachments.
  • asked a question related to Metabolic Diseases
Question
4 answers
I am collecting some data on BMI and looking at its relationship with diabetes/HTN or Dyslipidemia in our population. Given the present increase in obesity, there is always a question from the public, how likely will I get any of the above? I thought local data would be of some help in this regard.
Relevant answer
Answer
Insulin resistance correlate with BMI
  • asked a question related to Metabolic Diseases
Question
3 answers
First, have there been a research on repression of ChREBP-B gene expression and how would GLUT4 be affected?
Also, are there research on consequences or benefits of repression/expression of this particular gene?
Lastly, is this a mutated form of ChREBP-a and lead to metabolic diseases or a gene with necessary functions?
Relevant answer
Answer
Great question.
I was researching similar myself. GLUT4 would, apparently be less active at the surface. GLUT4 status and ChREBP influence each other via a few feedback loops.
  • asked a question related to Metabolic Diseases
Question
5 answers
Hi all,
I am an undergrad in a physiology lab. I am investigated the role of ferulic acid on certain markers. My PI proposed an experiment involving the overnight loading of high ferulic acid esterase producing bacteria onto cell culture. I'm having trouble finding a similar type of protocol in literature. I was thinking of heat-killing the bacteria, since FA is not a protein so potential aggregation would not be a problem. I'm unsure if there is a better technique available and I am simply lacking the term for the technique to looking into. Any help would be greatly appreciated.
Thanks
Romina
Relevant answer
Answer
Hi Romina, if that's the case, you can simply centrifuge the bacteria culture and apply the ferulic acid-rich supernatant to your cell culture. I guess you have certain kits to measure the ferulic acid level? As long as your concentration is the same as your commercial preparation, you should be fine. I do not recommend loading bacteria into the culture, alive or dead, because bacteria components may cause the cells to alter expression profile, hence you cannot be sure whether the change you observe is due to bacteria or the ferulic acid.
  • asked a question related to Metabolic Diseases
Question
5 answers
Vitamin D is interlinked with metabolic diseases which causes obesity, diabetes, CVDs, immune disorders, gut microbionta issues in human if sufficient Vitamin D is not provided. so, multiple sources of vitamin D are superfoods, sun exposure, skin types and some other sources, so how can we get rid of metabolic diseases through Vitamin D supplementation, Please highlight issues related to vitamain D and metabolic diseases to tackle these diseases.
Relevant answer
Answer
Fish and fish products, including salmon, herring, sardines, cod liver oil and tuna, are rich from vitamin D. Moreover, egg yolk and mushroom are also good soruces of vitamin D
  • asked a question related to Metabolic Diseases
Question
35 answers
The role of hyperglycemia, saturated fatty acids, oxidative stress, inflammatory cytokines have been investigated in causing insulin resistance. However, is hyperinsulinemia itself not likely to cause insulin resistance as a negative feedback mechanism?
Relevant answer
Answer
A very interesting exchange. I refer you all to a new review i had written on how hyper-insulinemia can cause insulin resistance (Najjar and Perdomo, Physiology, May issue-2019).
  • asked a question related to Metabolic Diseases
Question
2 answers
Thiazolidinedione (TZD) binds to nuclear transcriptional factor PPAR-gamma, thereby causing metabolic reprogramming. This drug for the treatment for insulin resistance in type-II DM has been modified into HA15, the novel compound leading ER stress by directly and specifically binding with BiP, also referred to as GFP78. This is the typical case of drug repositioning. Here, HA15 has been shown to promote the dissociation of the ER stress-related molecule complex composed of PERK, IRE1-alpha, and ATF4, therefore reducing the ATPase activity of BiP, which is responsible for the attenuated UPR potential. In addition to the fact that HA15 can overcome the therapeutic limitations against BRAF inhibitor-resistant melanoma cells, they do not at all affect the cellular viability of human normal fibroblasts or melanocytes. It is notable that they also harbor the similar ER stress machinery, but BiP in the normal cells does not seem to be disturbed. What is the difference of BiP (GRP78) between normal and malignant cells in the regulation of ER stress?? Si-RNA-mediated BiP depletion would be the useful experimental design?
Relevant answer
Answer
Hi Go,
Physiologically, GRP78 is a protein chaperone that maintains proper protein folding. Under normal conditions, GRP78 is normally found bound to ER membrane proteins, PERK, IRE1, and ATF6, keeping these proteins in an inactive state. When cellular events occurs, as Muruganandan Shanmugam addressed, GRP78 dissociates and allows each of PERK and IRE1 subunits to undergo homodimerization and ATF6 cleavage. This process activates the unfolded protein response.
However, there is a strange paradigm shift that is currently occurring in today's literature. In conditions of cancer, GRP78 is somehow able to escape the ER and relocate itself to the cell surface. It can associate itself with other cell surface receptors. Furthermore, auto-antibodies against GRP78 is able to trigger intracellular signalling.
  • asked a question related to Metabolic Diseases
Question
22 answers
According to common soil hypothesis metabolic diseases are associated with each other due to underlying insulin resistance.
What is your take on that?
Relevant answer
Answer
Inherited metabolic disorders are genetic conditions that result in metabolism problems. If it's can considered as linking so most people with inherited metabolic disorders have a defective gene that results in an enzyme deficiency. There are hundreds of different genetic metabolic disorders, and their symptoms, treatments, and prognoses vary widely.
  • asked a question related to Metabolic Diseases
Question
4 answers
Does anyone have any papers for the epidemiology of cardiometabolic disease in UK.
NOT cardiovascular disease.
Thanks.
Relevant answer
Answer
Follow
  • asked a question related to Metabolic Diseases
Question
27 answers
While patients with metabolic ailments like hypertension, diabetes, heart disease and cholesterol issues are already taking so many prescription medicines.
If we have to recommend any fruit to them what could be our preferable choices and for what reasons?
Relevant answer
Answer
Fruits without processing them an in moderate Portion sizes are beneficial. For fiber to give feelings of fullness and essential vitamins, berries, oranges, apricots, and apples are goood. For diabetIcs, they can be good with A1C and fighting inflammation.
  • asked a question related to Metabolic Diseases
Question
11 answers
Infectictous, metabolic, endokrinological, toxic, drug abuse, ect.
Relevant answer
Answer
Neuropathy is equivalent to computer CPU hardware malfunction, psychosis is equivalent to software malfunction. In my opinion, people's mental and psychological activities are a set of programs, which are similar to computer programs. Psychosis is a disorder of procedure. Enclosed are my papers on this subject
  • asked a question related to Metabolic Diseases
Question
5 answers
Dear esteemed colleagues,
Does anyone have any insight why most of the neuroendocrine studies, i.e hypothalamus-pituitary-peripheral organs axis, are mostly studied in mice? I do know some studies were done in rat, and even there are some rat animal models (HFD, genetic models, streptozocin, etc) but to my knowledge this is overwhelmingly minor compared to mouse models.
Is there any particular reason, such as mice neuroendocrine system more closely mimics human's? Or is there any technical reason? Thank you!
Relevant answer
Answer
Hi Yanuar
I've found lots of old papers in rats. Handling rats is always easier, their brain and bodies are x10 times larger, everything is easier with them. But since genetically modified animals are usually mice, they have become the species-of-use in the last two decades.
Optogenetics and pharmacogenetics can be done in rats as well, provided you get viral vectors designed for rats, which is not so difficult.
Both species are similar but not identical. Both are rodents, and good models for studying interesting issues for humans, I don't find advantages in mice or rats relative to their similarity to humans.
Good luck
Fernando
  • asked a question related to Metabolic Diseases
Question
35 answers
Multiple studies have recently highlighted association between vitamin D deficiency and metabolic disorders like hypercholessterolemia, diabetes, heart diseases and hypertension and others
Kindly have your say whether do you consider vitamin D deficiency as the main culprit behind these diseases or just an association implying a result following these diseases
Need you input please
Relevant answer
Answer
Vitamin D has well established effects on mineral metabolism, skeletal health, and recently established effects on the cardiovascular and immune systems. Vitamin D deficiency is highly prevalent and evidence is mounting that it contributes to the morbidity and mortality of multiple chronic diseases, including systemic lupus erythematosus.
Please have a look at these useful RG links and PDF attachments.
  • asked a question related to Metabolic Diseases
Question
4 answers
How can we upgrade the peptide yy in diet and control our obesity and get benefits from it for diabetes and other metabolic diseases. its best way that natural path be chosen for these types of diseases. in addition in bariatric surgery there is no removal or blockage of peptide yy pathway, is this true. herbal drugs if any effective for peptide yy to push or stimulate. Ghreline is another hormone which is also effective for diet control.
  • asked a question related to Metabolic Diseases
Question
36 answers
Please go through these 3 references:
1. An excerpt from wikipedia: (https://en.wikipedia.org/wiki/Lipid) reads:
"A few studies have suggested that total dietary fat intake is linked to an increased risk of obesity (Astrup, 2005; Astrup et al., 2008) and diabetes (Astrup, 2008). However, a number of very large studies, including the Women's Health Initiative Dietary Modification Trial, an eight-year study of 49,000 women, the Nurses' Health Study and the Health Professionals Follow-up Study, revealed no such links (Beresford et al., 2006; Howard et al., 2006). None of these studies suggested any connection between percentage of calories from fat and risk of cancer, heart disease, or weight gain."
2. Watch the video, Sugar the bitter truth by Robert H. Lustig, MD, UCSF professor of pediatrics in the division of endocrinology (https://www.youtube.com/watch?v=dBnniua6-oM).
Analogy: So is it logical to exonerate sugar and indict fat cholesterol as the major causes of heart diseases, increase in blood pressure, obesity, type 2 diabetes etc?
Relevant answer
Answer
I spent some time in eastern Africa as an environmental officer, my home was in Nairobi. On an assignment to Uganda, I ran across an old Brit MD and we discussed heart and vascular disease. He commented that the local diet was high in fat but that the prevalence of heart disease was low but had increased following the establishment of sugar plantations and refineries.
The fat may impact the ability of the endothelial cell to generate NO and the sugar generate ROS, thus pro inflammatory transcription factors, hence upregulation of ICAM-1
See, for example: Mitochondrial Reactive Oxygen Species Mediate Lysophosphadylcholine-induced Endothelial Cell Activation, by Xinyuan Li, et al.
Dr Edo McGowan
  • asked a question related to Metabolic Diseases
Question
5 answers
Epigenetics is very important branch, what are major researches have done, what new inventions have indicated in the treatment of obesity and diabetes or metabolic disorders, gene therapy or other related information for the benefits of humans.
Relevant answer
Answer
Dear Dr Malik,
maybe the following link can help you. It is a relatively recent paper, which is even linked on researchgate:
Yours sincerely,
Rainer
  • asked a question related to Metabolic Diseases
Question
9 answers
Losing body weight is one of the most searched topic on the net. Overweight and obesity become the root cause of majority of metabolic diseases and many kinds of cancer & other medical conditions.
A lady aged about 40 years has lost 23 kilograms (50.7 pounds) in a period of 6 months based on a dietitian diet.
Relevant answer
Answer
There are many factors that may affect weight loss as physical activity. We can expect healthy loss of weight based on a dietitian diet for 20 to 25 kg
  • asked a question related to Metabolic Diseases
Question
5 answers
Laboratory Animal models are very essential for measuring in-vitro and in-vivo test in animal models of diabetes and other diseases, alternative methods have launched like cell culture and spectroscopies and microscope levels. What are latest models including most commonly employed ones.
Relevant answer
Dear colleague,
As I see it, the classic has its charms. Drug-induced diabetes, such as in streptozotocin models, are not only prevalent in the literature, but also current. I found these interesting reviews on the topic:
And, of course, you can aways see what the companies are producing:
Sincerely,
Hércules Freitas
  • asked a question related to Metabolic Diseases
Question
1 answer
REFERENCES
1. Apelin and Sirtuin 1 Dysregulation induce Endocrine and Metabolic Disorders in Chronic Disease. 1(1). GJEM.000501. 2017.
2. The Future of Genomic Medicine Involves the Maintenance of Sirtuin 1 in Global Populations. Int J Mol Biol . 2017. 2(1): 00013. 
Relevant answer
Answer
May be, Immune system cells recognize their own tissue and show self-tolerance.
There are also healthy normal cells that control the immune system cells. However, genetic hormonal or environmental factors can change this balance. Because of this, the induction of autoimmune diseases is not dependent on endocrine and metabolism.
  • asked a question related to Metabolic Diseases
Question
13 answers
Anecdotally, much of the healthcare provided to people living with severe mental illness focuses on their mental health, negating physical health concerns including chronic disease. The co-morbidity of metabolic diseases (diabetes) and COPD (smoking) is especially large in this cohort, but are generally not receiving Management Plans from their GP, or are not following up referrals.
How can we improve these outcomes?
I'd like to hear your thoughts and inputs :)
Relevant answer
Answer
You ask an important question with far ranging implications and complex solutions.
I think the best framework to use in approaching this question is a model developed for  the US Institute Medicine. In practical terms, it recommends four categories of care (Wellness Basics, Restorative Therapies, Symptom Relief, Over-care avoidance - these are not the names they use, but are ones that are much easier to grasp).
I think the best way to answer your question is to  restate it, "what is the best way to optimize physical health in each of the four categories of care, for someone with severe mental illness?". I think the restatement is important, because the answers in each category are different. Typically, activity is required in all categories at the same time. In addition, these approaches are best deployed within the context of a recovery model of evolutionary improvement and ever-increasing self-determination.
I'll assert the highest level answer in all four categories.
Wellness Basics. These include 1) Housing & Security, 2) Diet & Digestion, 3) Exercise & Sleep, 4) Calm Awareness, 5) Effective Self-Management, 6) Purpose & Meaning, 7) Social & Outer Engagement, 8) Belief, Hope & Self-Transcendence. There are hundreds of RCTs that support that doing the right things in these areas directly support both mental and physical health. For instance, housing is the absolute first thing that one must do to support the physical wellness of someone with severe mental illness. Without it, their life nearly always remains in shambles. Approaches to wellness in this category are normal disciplines of wellness for everyone and are fairly well understood, though not always within reach. The challenge here is that these approaches often requires self-determination and lifestyle changes, things that can be extremely hard for people with severe mental illness. But, the good news here is that most of these things do not require medical intervention and can often, with a little creativity, be found without huge expense.
Restorative Therapies. These are mental health interventions targeted at suspected root causes of mental health symptoms, divided into two groups: Biomedical and Psychosocial. The Biomedical ones are directly tied to both physical health and mental health. Things like Nutrient therapy, Pathogen therapy, Endocrine therapy, Food Allergy Therapy, detoxification therapy, etc. are all therapeutic responses to physical issues that are well-known to potentially cause mental health symptoms. Approaches to wellness in this category are squarely within the medical discipline. It demands - though it is rare in conventional psychiatry today - robust biomedical testing. This testing is one of the cornerstones of integrative psychiatry, which is producing recovery rates substantially higher than those from drug therapy alone (the best evidence of this is through extensive open-label trials with Nutrient Therapy). Dr. Michael First, editor of the DSM-5 laments that current psychiatry often jumps to symptom-based diagnoses and all but avoids step three of the differential diagnosis process (the step that looks for underlying causative issues).
Symptom Relief. Effort here is to relieve residual mental health symptoms that the first two categories don't address. Psychotropics are by far the most common option here, but there are others with a smaller, but non-trivial evidence base: herbs, very small current electro-stimulation devices (like tDCS, tACS, CES, etc.), sensory therapy, etc. This area is predominantly tangential to the issue of physical health, with one exception. Symptom relief to some degree is often a mandatory first step to achieve stabilization. It is only after some measure of stabilization that we can even begin to consider improving physical health through approaches in the first two categories of care.
Over-care avoidance. This is a huge challenge in psychiatry today. Ill-advised polypharmacy and off-label prescribing, prescribing at dosages over recommended levels, over prescribing of psychotropics to vulnerable populations (the elderly, veterans, foster children...) and probably the most detrimental - antipsychotic polypharmacy - have been known to substantially impact physical health negatively. These are well understood by the APA and they have campaigns to reel-in some of these, especially antipsychotic polypharmacy. This has a huge implication on physical health. Outcomes from overcare are stark: significantly increased chances of death and a far ranging list of serious side effects.
So, how do we ensure the physical health of people with severe mental illness? 1) Focus outside of the medical discipline on the most out-of-balance wellness basics to establish new healthier lifestyle choices, 2) through robust biomedical testing, search for and address any physical issues found that are commonly known to cause mental health issues, 3) do enough symptom relief to reach a measure of stability so that a focus on physical health can be begun, 4) be ever vigilant to avoid over-care and seek "minimal effective dosages", starting dosages small and ramping slowly, 5) deliver these wellness approaches within the context of a recovery model that maximizes self-determination and recognizes that recovery is an iterative, evolutionary process where setbacks are common.
To deliver the above in a coordinated way is extremely difficult today and, to be done well, requires a holistic approach to patient care. I think to make substantive progress, we need to adopt something similar to this 4-categories of care model and train case workers on its fundamentals and how they can help individuals map into available services in each area.
  • asked a question related to Metabolic Diseases
Question
2 answers
Homocystinuria is a metabolic error of the homocysteine, which can be caused by the deficiency of different enzymes. The most frequent is the deficiency of cystathionine β-synthase (CBS), also called classical homocystinuria. Because of this, amino acids are accumulated, like homocysteine and methionine, while others are deficient, like the cysteine. This last amino acid is a precursor of other important metabolic substances, like for example, glutathione, which is an important antioxidant and can be deficient in homocystinuria.
I wonder why impaired synthesis of GSH does not cause the oxidative stress-induced tissue damage?
Which organs or tissues CBS is expressed can explain the absence of the symptoms related to redox stress.
Relevant answer
Answer
Interesting question, probably in cells of patients GSH is not depleted, due to the fact that they can use cysteine whose origin is not methionine/hCys (Trans sulfurathion patwhway). Do you have any reference for GSH levels in tissues these patients? I have performed some experiments with cells with methionine free medium whose cysteine levels (and GSH too)  is minimally influenced by the absence of methionine.
  • asked a question related to Metabolic Diseases
Question
13 answers
Is there a research niche that really needs a Cobas Fara analyser? What is it that other modern analysers miss? Would a modernised version be of interest or is it surpassed as a technology?
Relevant answer
Answer
I would be very interested to know if anyone has any idea of how many FARA's are still used routinely. No scientific basis for my request, just that I was a Roche customer for many years from 1978, first with Centrifichem, COBAS BIO and then FARA...then I worked for Roche for the past 26 years and will retire next year. For me the FARA was the most wonderful and flexible invention, and I was able to automate so many applications in my lab at that time. It would be nice to give it a mention in my closing speech...there are are still people working here in R&D in Switzerland who remember it fondly...
  • asked a question related to Metabolic Diseases
Question
4 answers
I am using Michigan Hand Questionnaire.
Relevant answer
Answer
Dear Ngu LH
If you are interested in cooparation in this field, please send me an email at marcos.almeida@hotmail.com.
Thank you
  • asked a question related to Metabolic Diseases
Question
1 answer
Let me know a manufacturer of copper-histidine API for a solution for treatment of Menkes
Relevant answer
Answer
Dear Alejandro,
Herein the company address:
Casno:5610-61-7
Copper Histidine
Copper Histidine
Min.Order: 0
FOB Price:   0.0 /0.0
1. high quality2. competitive price3. professional manufacturer4. best service5. loyal and honest supplierAppearance:according to the COA Storage:Store in dry, dark and ventilated place Package:1)1Kg as a sample order:Aluminum foil bag with double pl
Junhao, established in the year 2010, is headquartered in Quzhou City, also known as "The Capital of Chemicals" in China. We are in the global Specialty Chemical Industry. Thanks t
Zhejiang Junhao Chemical Co., Ltd.
  China (Mainland)  |  Contact Details
Business Type:Trading Company
Tel:86-0570-8350918
Address:No. 131/133, Longhua Road, Kecheng District
You can make your order using the following link:
Rafik
  • asked a question related to Metabolic Diseases
Question
4 answers
Hello,
Sorry for the English, it is basic.
I studied some recommendations of exercises for people with McArdle's disease, and found no reference to water aerobics activities (discarding swimming). They could give me a guidance?
thank you
Relevant answer
Answer
Swimming or aquatic exercise may not be the best form of exercise for McArdle patients simply because it may challenge their balance and if they have to rapidly correct, it will cause a rapid muscle contraction which could lead to a contracture.
The advice for most patients with this condition would simply be to use walking in their everyday lives. Overload is useful for applying a stimulus; that will cause adaptation and, ultimately improve function. However, it is very important that all individuals with McArdle disease start exercise at a very low intensity. Even this can elicit pain and so the patient may need to slow down or stop until the pain has reduced or has gone. They should then start walking again or walk a little faster, this process should, continue until they reach a pace that they can walk at for around 10 minutes. Over 12-16weeks, it should be possible to increase the duration of walking until they are able to walk continuously with no, or only very mild, pain for 30 minutes. The ultimate plan is to build this up until patients are able to take 150 minutes of exercise per week. This is the recommended amount of exercise suggested by most guidelines as the minimum required to reduce risks to health. Of course, being a minimum, people should aim to do even more.....but one step at a time!
  • asked a question related to Metabolic Diseases
Question
3 answers
I want to predict what Gram-ve intestinal flora would be interacting with host (human) genes, protein or transcription factors to cause or promote metabolic diseases. I know Toll like receptors involvement in DM2, Insulin resistance but its not the complete story. I want to predict this interaction using a computational approach to fulfill my idea.
Thanks if you have time to answer.
Relevant answer
  • asked a question related to Metabolic Diseases
Question
4 answers
Hypophosphatemio is a verz dangerous metabolic situation by many patients, specillz in intenzive care unit, by status epilpticus, ect. It is necessery to proof the nvou of Phosphor, not only the standard electrolits. The correction must be very fast, because the start symptoms are unspecific, and the end can be paralysis of respiratorz muscels, coma and death.
Relevant answer
Answer
Whereas severe hypophosphatemia may lead to acute hemolytic anemia, decreased myocardial contractility, neuromuscular disturbance, respiratory weakness or even rhabdomyolysis and altered mental status, its impact on survival remains questionable.
At evidence no effect in DKA In contrast with a potential prognosis factor in case of AKI which received CVVH therapy.
Even, if we observed rare case of acute severe hypophosphatemia in acute exacerbation of COPD, its role on respiratory failure could not be established: severe respiratory acidosis or metabolic alkalosis during the first days of mechanical ventilation???
Two publications could be helpful, but the question remains of interest.
  • asked a question related to Metabolic Diseases
Question
8 answers
Currently, bariatric & metabolic surgeons offer surgery for remission of DM in 'poorly controlled' T2DM patients. What exactly is 'poorly controlled' DM? Are there any guidelines?
Relevant answer
Answer
Rangarajan, what fails as therapy for one population may work for another. As for lifestyle intervention, this is a radical change in eating behavior and attitudes towards eating and physical activity that starts with small changes. The thinking about health has to change first and the behaviors need to follow. For example, a lifestyle change for persons with type 2 diabetes could be exchanging fried food with baked food or using the stairs instead of the elevator. Patient selection refers to making a scientific study by narrowing the differences between the patients in areas of length of time with diabetes, previous diabetes education, culture/ethnic health beliefs...etc.
  • asked a question related to Metabolic Diseases
Question
4 answers
Hi,
I was just wondering how tight junctions contribute to the development of diseases and if there is any known connection between Claudin 6 expression in developmental programming and/or the development of metabolic diseases?
Any thoughts/ comments?
Thanks,
Pooja.
Relevant answer
Answer
Oligodendrocyte-specific protein (OSP/claudin-11) is a four transmembrane protein concentrated in central nervous system myelin. Recent evidence has emerged suggesting that OSP/claudin-11 is involved in membrane interactions at tight junctions and with the extracellular matrix. OSP/claudin-11 seems to modulate proliferation and migration of oligodendrocytes presumably through these interactions. Furthermore, evidence is presented implicating OSP/claudin-11 as an autoantigen in the development of autoimmune demyelinating disease.
J Neurosci Res. 2000 Mar 15;59(6):706-11.
  • asked a question related to Metabolic Diseases
Question
7 answers
It has been reported that in Niemann Pick disease Sphingosine accumulates in lysosomes and late endosomes. I attached one of the good studies regarding this disease.
However it is not clear why sphingosine levels will rise with the disease.
Niemann-Pick disease types A and B is caused by mutations in the SMPD1 gene. This gene provides instructions for producing an enzyme called acid sphingomyelinase. This enzyme is found in lysosomes, which are compartments within cells that break down and recycle different types of molecules. Acid sphingomyelinase is responsible for the conversion of a fat (lipid) called sphingomyelin into another type of lipid called ceramide. Mutations in SMPD1 lead to a shortage of acid sphingomyelinase, which results in reduced break down of sphingomyelin, causing this fat to accumulate in cells.
Sphingosine is producued through breakdown of ceramide by ceramidase. 
Normally, one would expect decreased levels of Sphingosine following inhibition of ASM. Then why and how Sphingosine accumulates in Niemenn Pick disease?
Relevant answer
Answer
I have read the given answers, but should like to add the following: You should differentiate between the sphingosine accumulaton in NP disease type C (NPC; defective NPC1-protein) and that in NP types A and B (acid sphingomyelinase/SMPD1 defect). In NPC lipds aside of cholesterol are accumulated within the lysosome but sphingomyelinase, though low, is still present, as is acid ceramidase. Due to the lipid trafficking jam, enzymatically released sphingosine cannot be released from the lysosome nor be re-utilized, therefore it may accumulate, and eventually, after cell death, even (partially) appear in blood plasma. To this process (if true), there may add a similar process, but starting from glycolipids (for, example, lac-cer and Gb3 which are also accumulated), leading to additional sphingosine enhancement.
In NPA/B (sphingomyelinase deficiency), sphingomyelin-derived ceramide and subsequent sphingosine release should be low, but there may be also some secondary lipid trafficking jam out of the lysosome, suggested by some cholesterol accumulation also seen in NPA/B, which, secondary to the lysosomal sphingomyelin accumulation, may lead also to some lysosomal retention of glycolipid-derived sphingosine, which may become enhanced as described above.
I am not very sure about my hypothesis, but I think it could be discussed.
  • asked a question related to Metabolic Diseases
Question
2 answers
I am validating a Transferrin saturation test in the order to replace the unsaturated iron binding capacity (UIBC) and am looking for any recent info comparing the two tests.
Relevant answer
Answer
In the context of Haemochromatosis :
  • asked a question related to Metabolic Diseases
Question
4 answers
Does the geriatric population have widespread but unrecognized insufficiency of the adrenal cortex?  Could this partly explain weight loss and depression in that age group?
Relevant answer
In critical geriatrics inpatients you should always think if there is a subclinical Addison's disease in order to supplement a little of corticosteroid and get better results in your therapy and toward  the recover of the patient
  • asked a question related to Metabolic Diseases
Question
2 answers
I always have students calibrate the various components of our metabolic cart (e.g., mass air flow meter, O2 analyzer, CO2 analyzer). However, I am not sure what the total error of measurement is for final measurements such as VO2, VCO2, R, etc. I'd like to present a method to my students that would allow them to calculate the propagation of error for any complex measurement they might make in lab.
Relevant answer
Answer
In the following paper a calibration methodology for metabolic analyzer and the estimation of uncetainty have been described.
  • asked a question related to Metabolic Diseases
Question
6 answers
When studying some metabolic parameters in elderly people, it seems difficult to distinguish which ones are caused by aging per se or by age-related diseases. In particular, circulating IL-6 is known to increase with age but is it a relevant biomarker of aging since it is also elevated in metabolic diseases such as obesity or atherosclerosis. Then, is there a very specific biomarker of aging?
How can we characterize healthy elderly? For the recruitment of such cohort, do we exclude all kind of diseases or can we tolerate some?
Relevant answer
Answer
I am not unbiased, as you can imagine. The answer also depends on your objectives. I am skeptical about the distinction about aging and age-related diseases and also try to avoid going to semantics. There are many biomarkers of aging but all they are "weak", in a sense. Using the frailty index approach we can find a summary measure that is much superior to any single biomarker.  Aging is a systemic property of the organism therefore any assessment should also be systemic, i.e. to combine available information.  Such information can be based on clinical assessment  or even self-reports but also can be more "objective". Take a look at the recent paper Howlett et al. BMC Medicine, 2014 where the lab tests were combined together in a FI-Lab. To go in this direction you should not hate math, although math is very basic.
Arnold
  • asked a question related to Metabolic Diseases
Question
5 answers
We are looking at predicting adherence to medical and behavioral health care recommendations among individuals with metabolic syndrome. I'm curious if anyone might be able to provide personal insight into specific indicators (behavioral or otherwise) that have been effective/reliable in quantifying the construct of treatment adherence?
Relevant answer
Answer
Successful management requires identification and addressing both root cause, barrier. Patient vary considerably in their readiness and capacity. Success can be defied as better quality of life. greater self esteem. higher energy level etc. There is an approach for obesity management from Canadian obesity network: www.obesitynetwork.ca
  • asked a question related to Metabolic Diseases
Question
12 answers
Overexpression of uncoupling proteins in small rodents is an effective way to alter thermogenesis. This strategy prevents diet induced obesity and insulin resistance (link 1). There is now substantial interest in alternative methods of increasing thermogenesis as a means to treat obesity (links 2 and 3). However, due to the volume : surface ratio, small rodents have a high tolerance for elevated thermogenesis (link 4) as a result of UCP overexpression. Humans have a much lower surface area : volume ratio and therefore have a reduced capacity to dissipate heat. Therefore, will overweight humans have a sufficient tolerance for enhanced thermogenesis for this to be a safe and viable treatment option?
Relevant answer
Answer
although most of research on obesity is concenrating on white adipose tissue and the development,differentiation ie hypertrophy and hyperplasia of adipocytes and pfeadipocyytes in WAT and role of inflammation and macrophage infiltration directly or conversion of preadi[ocytes,metabolic endotoxemia,gut microbiota lreading to increased LPS absorption from increased GIT permeability with altered gut microbiota is some of the aetiopathogenesis with infiltration of Treg cells,cdt4. CHT8 cellsiNKT CELLS th17 all have ben found but importance is being given simultaneously to the microrna which affect the differentiATION OF BRITE AND BROWN ADIPOCYTES AND IMPORTANCE OF MIrna'S 26,155,27a,b,130 a ,miR155 etc in adipocyte differentiation and how further roles of FGF21 may affect thermogenesis and natriureteic peptides
  • asked a question related to Metabolic Diseases
Question
17 answers
I have induced type 2 diabetes mailitus using high fat diet (45% fat) plus multiple low dose of streptozotocin (30mg). So can any please tell me Which type insulin (Short, log, Intermidiate acting or Biphasic insuline) should be used to carry out Insulin Tolerance Test in type 2 diabetic rats?
Relevant answer
Answer
I would recommend the most "normal" formulation you can find. In my lab, we use Humulin R, but any simliar brand should work. I don't use any of the especially fast acting analogs, just plain insulin. Get your baseline, inject IP and begin collecting your time points.
  • asked a question related to Metabolic Diseases
Question
22 answers
Recent studies suggest that there is still a benefit without significantly increasing side effects, but I'm not convinced that long term or in certain subgroups of patients, the metabolic change that we generate with very aggressive treatment is safe.
Relevant answer
Answer
The original question was what do we have to monitor with high statin therapy. If we use other therapies may other metabolic Parameters would also have to be considered. In statin therapy I would monitor lipids, glucose and HbA1c, ALAT, may be  CK (at least at the beginning) and eventually hsCRP.
  • asked a question related to Metabolic Diseases
Question
6 answers
Apart from the effects of dietary changes and variable therapeutic compliance,do you know if there are other sources of comorbidity (apart of diabetes, thyroid status and cholestasis) that may cause significant and temporary variation in the concentrations of major lipoproteins (without the pharmacological treatment) ?.
Relevant answer
Answer
Bile malabsorption can also increase serum triglyceride levels, while decreasing the cholesterol pool. This might be an autoimmune phenomenon, but I'd love to hear anyone's thoughts on the matter. And yes, these changes may be transient.
  • asked a question related to Metabolic Diseases
Question
4 answers
IL-18 is specific bio-marker of metabolic syndrome.
Relevant answer
Answer
Thank you Sir...
  • asked a question related to Metabolic Diseases
Question
4 answers
For free radicals activities directly affected in metabolic syndromes.
Relevant answer
Answer
Thank you sir,
But, you can send any research articles which followed this type of  protocols for serum.
  • asked a question related to Metabolic Diseases
Question
5 answers
NAFLD shares many overlapping features with the insulin resistance syndrome, also known as "Syndrome X" including central or visceral obesity, type II diabetes, and dyslipidemia. Of course, NAFLD is now recognized as a hepatic manifestation of insulin resistance syndrome.
Relevant answer
Answer
Insulin resistance prevalence is very high among patients with NASH (60-85%). In fact it is pathophysiologically implicated in NAFLD in most of patients. None less, not all patients with NASH have insulin resistance. In the other hand, insulin resistance and DM are detected in 17 – 35% of patients with chronic hepatitis C. The mechanisms by which HCV produces insulin resistance and DM are not clearly known.  It was observed that HCV induces insulin resistance regardless of body mass index and fibrosis stage. In a study conducted in a transgenic animal model, the HCV core protein was able to induce insulin resistance, steatosis and DM. In addition, insulin resistance induces antiviral treatment resistance in HCV patients and it is associated to in increments of mortality. I attached one publication that can be of help in this field.
 Liver cirrhosis and diabetes: Risk factors, pathophysiology,clinical implications and management. World J Gastroenterol 2009;15:280.
  • asked a question related to Metabolic Diseases
Question
9 answers
Several dedicated centers have published data regarding this, but our diabetology friends beg to differ. Any (unbiased!) thoughts?
Relevant answer
Answer
jejuno-ileal Bypass was practiced for Hypercholesterlemia also .It very effectively cures the problem but adds several other problems including fractures due to severe malabsorption,hence this is not being practiced.I had an opportunity to reverse one.
  • asked a question related to Metabolic Diseases
Question
13 answers
Diabetes is a group of metabolic diseases in which a person has high blood sugar. This high blood sugar produces the symptoms of frequent urination, increased thirst, and increased hunger. Untreated, diabetes can cause many complications. Acute complications include diabetic ketoacidosis and nonketotic hyperosmolar coma. Serious long-term complications include heart disease, kidney failure, and damage to the eyes. Thus, I am looking for some new natural products to test them as anti-diabetic remedy in an animal model.
Relevant answer
Answer
Vijayendra:
Glad to help. Fenugreek is a good choice, but just here are a few tips culled from review:
(1) Only trials that administered Fenugreek seed powder in upper dose range (>= 5g) achieved a significant reduction in glucose parameters to a clinically releevant degree;
(2) Low doses (< 2 g) of hydro-alcoholic extracts were ineffective;
(3) The upper dose range that includes doses from 5 - 25 g of fenugreek seed powder provided an additional benefit, of also lowering postprandial glucose levels, again to a clinically releevant degree; this was true of fenugreek raw seeds, extracted seed powder, cooked seeds (dosed at 25 g) and gum isolate of seeds (dosed at 5 g) while degummed seeds (even up to 25 g) had negligible effect.
  • asked a question related to Metabolic Diseases
Question
6 answers
I used to follow ITO's method but I need something less time consuming? Any suggestions? Any other HPLC method more useful in routine analysis?
Relevant answer
Answer
Sialic acid
  • asked a question related to Metabolic Diseases
Question
1 answer
Does glutaric acid accumulate as a result of reduced carnitine availability? As a consequence of a lack of detoxification?
Relevant answer
Answer
I do not think is because reduced carnitine availability.
The combined metabolic derangements seen in MADD are all due to deficient activity Electron Transfer Flavoprotein (ETF) and/or its electron transfer flavoprotein:ubiquinone oxidoreductase ( ETF: QO) which impairs all FAD-dependent dehydrogenases .
Glutaric acid accumulates as a result of deficient Glutaryl-CoA dehydrogenase (FAD-dependent enzyme ) and reduced carnitine availability is secondary to accumulation of short- and medium-chain acylcarnitines due to impaired acyl-coenzyme A dehydrogenases (FAD-dependent enzymes ).
Note : Some MADD patients had normal ETF and ETF-QO activity, suggesting other unknown disease mechanisms.
  • asked a question related to Metabolic Diseases
Question
15 answers
Metabolic syndrome includes several features that are amenable to short term trials. Hypertension due to stimulation of sodium resorption by insulin on the renal distal tubule responds quickly reducing insulin levels with very low sugar (carbohydrate) ketogenic diets (VLCKD). A trial of persons with hypertension would help to answer the question of whether primary hypertension is caused by this functional hyperinsulinemia. For midwives and obstetricians, the observation of hypertension and pre-eclampsia may indicate that a small trial would be worthwhile in women at relatively low risk for eclampsia.
While type 2 diabetes responds well to VLCKD's in randomized clinical trials, determining whether the reductions in inflammatory markers will either slow or stop progression of Alzheimer's type or inflammatory dementia are urgently needed and a proof of concept trial would not take a large number of subjects as the clinical course is generally progressive. Prevention of inflammatory dementias would take a much larger randomized trial but as dementia is a complication of type 2 diabetes and by association, metabolic syndrome, there may be a reasonable assumption of a positive trial. There is some evidence that this will be efficacious but in a non-definitive trial. Likewise the mood disorder associated with metabolic syndrome could be tested in a relatively small clinical trial.
As the adverse effects of VLCKD's are minimal, applications for the ethics approval for such clinical trials should not be difficult to obtain.
For clinicians wishing to carry out clinical trials in relatively small numbers of individuals as a precursor to obtaining funding and ethics approval for larger, more definitive trials, these trials are important clinically as the conditions are common and the trials feasible for the same reasons. Positive trials may affect the management of patients commonly seen in clinical practice through well funded larger randomized controlled trials.
.
Relevant answer
Answer
Metabolic syndrome is characterized by cardiometabolic risk factors that include obesity, insulin resistance, hypertension and dyslipidemia. Oxidative stress is known to play a major role in the pathogenesis of metabolic syndrome. The objective of this study was to examine the effectiveness of hydrogen rich water (1.5-2 L/day) in an open label, 8-week study on 20 subjects with potential metabolic syndrome. Hydrogen rich water was produced, by placing a metallic magnesium stick into drinking water (hydrogen concentration; 0.55-0.65 mM), by the following chemical reaction; Mg + 2H(2)O --> Mg (OH)(2) + H(2). The consumption of hydrogen rich water for 8 weeks resulted in a 39% increase (p<0.05) in antioxidant enzyme superoxide dismutase (SOD) and a 43% decrease (p<0.05) in thiobarbituric acid reactive substances (TBARS) in urine. Further, subjects demonstrated an 8% increase in high density lipoprotein (HDL)-cholesterol and a 13% decrease in total cholesterol/HDL-cholesterol from baseline to week 4. There was no change in fasting glucose levels during the 8 week study. In conclusion, drinking hydrogen rich water represents a potentially novel therapeutic and preventive strategy for metabolic syndrome. The portable magnesium stick was a safe, easy and effective method of delivering hydrogen rich water for daily consumption by participants in the study.
PMID:
20216947
[PubMed]
PMCID:
PMC2831093
Free PMC Article
  • asked a question related to Metabolic Diseases
Question
6 answers
We have a 9-old month infant with high level of blood Glycine. Urine for organic acids showed high levels of methyl malonic acid,, increased 3-OH-propionic acid & methyl citric acid. She has recurrent seizures, acidotic breathing and malnutrition. Her diet is Soya milk, boiled rice & vegetables.
Relevant answer
Answer
Vitamin B 12 level was not measured (low-Resource setting).However she is having B 12 one mg intramuscular every 7days. Tiglylglycine, and propionylglycine were not measured.